Gregory Adams, PhDChief Scientific Officer at Elucida Oncology
Agenda Sessions
Co-Chairs’ Remarks
, 2:10pmView SessionTargeted C'Dot Drug Conjugates (CDCs): Preclinical Development of a VHH-CDC and ELU001 Phase 1 Study Results
, 4:15pmView Session